Skip to main content
. 2015 Mar 30;35(11):1292–1308. doi: 10.1002/jat.3132

Figure 1.

Figure 1

Benchmark dose modeling results of uterine effects in female rats. (A) Incidence of combined uterine tumors from the National Toxicology Program (NTP, 2013). (B) Incidence of uterine hyperplasia (NTP, 2013). Note: the highest dose group was dropped for modeling uterine hyperplasia in order to improve model fit.